Transplant Diagnostics Market by Molecular and Non-Molecular Assay Technology (Serological assay, Mixed Lymphocyte Culture, PCR Based, Sequencing Based), End-User (Hospitals and transplant centers, Research laboratories and academic institutes, Commercial

Transplant Diagnostics Market by Molecular and Non-Molecular Assay Technology (Serological assay, Mixed Lymphocyte Culture, PCR Based, Sequencing Based), End-User (Hospitals and transplant centers, Research laboratories and academic institutes, Commercial


  • Products Id :- LI 161135
  • |
  • Pages: 138
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Transplant diagnostics are tests that are performed pre and post-transplant procedures to check the compatibility between the donor and recipient of organ and its suitability in the body. It is mainly required to reduce the risk of organ rejection that can take place due to incompatible donors. Post-transplant, series of diagnostics tests are performed to check the chances of organ rejection.

The world transplant diagnostics market is projected to reach $1,031 million by 2022 and this growth is fueled by factors such as increasing elderly population, increased incidences of chronic disease patients, and increased focus on R&D. The market for transplant diagnostics is flanked with technological progression that is stimulated by increasing awareness related importance of organ donations. Although these factors will drive the market for transplant diagnostics there are certain elements that can limit the growth of the market. Worldwide scenario for organ shortage and difficulties in HLA sequencing can restrict the growth of the market.

The transplant diagnostics market is segmented on the basis of technology, components, application, end-users, type of organ, type of screening, and geography. The world transplant diagnostics market based on the technology is segmented into non-molecular assay and molecular assay technologies. The non-molecular assay technologies are further categorized as serological assay and Mixed Lymphocyte Culture (MLC) assay. The molecular assay technology is categorized into PCR-based and sequencing based. The global transplant diagnostics market based on the components is classified into instruments, reagents and consumables, and software and services. The transplant diagnostics market based on end-user is categorized as hospitals and transplant centers, research laboratories and academic institutes, and commercial service provider. On the bases of applications, the transplant diagnostics market is broadly classified into research and diagnostics. Further the market based on the type of organ is segmented into kidney, liver, heart, lung, pancreas, and others. On the bases of type of screening the market is categorized into pre-transplant screening and post-transplant screening. By geography the market is divided into North America, Europe, Asia Pacific and ROW including further segmentation of the major countries. The key players in the transplant diagnostics market are focused on strategies such as product approval and launches, merger and acquisition, expansion, collaboration etc. to expand their market share.

KEY BENEFITS FOR STAKEHOLDERS:

This report provides an extensive analysis of the current and emerging market trends and dynamics in the world transplant diagnostics market.

In-depth analysis has been done in this report by constructing market estimations for the key market segments between 2014 and 2022.

Comprehensive analysis of factors that drive and restrict the growth of the world transplant diagnostics market is provided.

Exhaustive analysis of the world transplant diagnostics market by technology helps in understanding the current range of the product available for commercial usage.

Competitive intelligence helps in understanding the competitive scenario across the geographies

Key market players within the world transplant diagnostics market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the market.

KEY MARKET SEGMENTS:

World transplant diagnostics market is segmented as:

By Technology

Non-Molecular assay

Serological assay

Mixed Lymphocyte Culture

Molecular assay

PCR Based

Sequencing Based

By Component

Instrument and Equipment

Reagent and consumables

Software and services

By End-User

Hospitals and transplant centers

Research laboratories and academic institutes

Commercial Service Providers

By Applications

Research

Diagnostic

By Organ Type

Kidney

Liver

Heart

Lung

Pancreas

Others

By Screening Type

Pre-Transplant Screening

Post-Transplant Screening

By Region

North America

U.S.

Canada

Mexic

Rest of North America

Europe

UK

Germany

France

Spain

Italy

Turkey

Rest of Europe

Asia-Pacific

Australia

South Korea

New Zealand

Japan

China

Rest of Asia-Pacific

LAMEA

Brazil

Israel

Iran

Saudi Arabia

Rest of LAMEA



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

CHAPTER 1 INTRODUCTION

1.1 Report description

1.2 Key Benefits

1.3 Key Market Segments

1.4 Research Methodology

1.4.1 Saecondary Research

1.4.2 Primary Research

1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope

3.2 Key Findings

3.2.1 Top Investment Pockets

3.2.2 Top Winning Strategies

3.3 Porters Five Forces Analysis

3.3.1 Bargaining Power of Suppliers

3.3.2 Bargaining Power of Buyers

3.3.3 Threat of New Entrants

3.3.4 High Intensity of Rivalry

3.3.5 Threat of Substitutes

3.4 Top Player Positioning, 2015

3.5 Market Dynamics

3.5.1 Drivers

3.5.1.1 Increasing aging population

3.5.1.2 Increased incidence of chronic diseases

3.5.1.3 Increased focus on R&D

3.5.2 Restraints

3.5.2.1 organ shortage worldwide

3.5.2.2 Difficulties in HLA sequencing

3.5.3 Opportunities

3.5.3.1 Shift from traditional methods to modern techniques for HLA typing

3.5.3.2 Increasing demand for organ transplant procedures

3.5.3.3 Mergers & acquisitions

CHAPTER 4 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY

4.1 Overview

4.1.1 Market Size and Forecast

4.2 Non-Molecular Assays

4.2.1 Key Market Trends

4.2.2 Key Growth Factors and Opportunities

4.2.3 Market Size and Forecast

4.2.4 Serological Assays

4.2.4.1 Market size and forecast

4.2.5 Mixed Lymphocyte Culture Assays

4.2.5.1 Market size and forecast

4.3 Molecular Assays

4.3.1 Key Market Trends

4.3.2 Key Growth Factors and Opportunities

4.3.3 Market Size and Forecast

4.3.3.1 PCR-based molecular assay

4.3.3.2 Market size and forecast

4.3.3.3 sequencing-based molecular assay

4.3.3.4 Market size and forecast

CHAPTER 5 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY COMPONENT

5.1 Overview

5.2 Consumables and Reagents

5.2.1 Market Size and Forecast

5.3 Instruments and Equipment

5.3.1 Market Size and Forecast

5.4 Software and Services

5.4.1 Market Size and Forecast

CHAPTER 6 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY END USER

6.1 Overview

6.1.1 Market Size and Forecast

6.2 Hospitals and Transplant Centers

6.2.1 Market Size and Forecast

6.3 Research Laboratories and Academic Institutions

6.3.1 Market Size and Forecast

6.4 Commercial Service Providers

6.4.1 Market Size and Forecast

CHAPTER 7 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION

7.1 Overview

7.2 Research

7.2.1 Market Size and Forecast

7.3 Diagnostics

7.3.1 Market Size and Forecast

CHAPTER 8 WORLD TRANSPLANT DIAGNOSTICS MARKET BY ORGAN TYPE

8.1 Overview

8.2 Kidney

8.2.1 Market size and forecast

8.3 Liver

8.3.1 Market size and forecast

8.4 Heart

8.4.1 Market size and forecast

8.5 Lung

8.5.1 Market size and forecast

8.6 Pancreas

8.6.1 Market size and forecast

8.7 Others

8.7.1 Market size and forecast

CHAPTER 9 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TYPE OF SCREENING

9.1 Overview

9.2 Pretransplant Screening

9.2.1 Market Size and Forecast

9.3 Posttransplant Screening

9.3.1 Market Size and Forecast

CHAPTER 10 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY GEOGRAPHY

10.1 Overview

10.1.1 Market Size and Forecast

10.2 North America

10.2.1 Key Market Trends

10.2.2 Key Growth Factors and Opportunities

10.2.3 Market Size and Forecast

10.2.4 U.S.: Market Size and Forecast

10.2.5 Canada: Market Size and Forecast

10.2.6 Mexico: Market Size and Forecast

10.3 Europe

10.3.1 Key Market Trends

10.3.2 Key Growth Factors and Opportunities

10.3.3 Market Size and Forecast

10.3.4 UK: Market Size and Forecast

10.3.5 Germany: Market Size and Forecast

10.3.6 France: Market Size and Forecast

10.3.7 Spain: Market Size and Forecast

10.3.8 Italy: Market Size and Forecast

10.3.9 Turkey: Market Size and Forecast

10.3.10 Rest of Europe: Market Size and Forecast

10.4 Asia-Pacific

10.4.1 Key Market Trends

10.4.2 Key Growth Factors and Opportunities

10.4.3 Market Size and Forecast

10.4.4 Australia: Market Size and Forecast

10.4.5 South Korea: Market Size and Forecast

10.4.6 New Zealand: Market Size and Forecast

10.4.7 China: Market Size and Forecast

10.4.8 Japan: Market Size and Forecast

10.4.9 Rest of Asia-Pacific: Market Size and Forecast

10.5 LAMEA

10.5.1 Key Market Trends

10.5.2 Key Growth Factors and Opportunities

10.5.3 Market Size and Forecast

10.5.4 Brazil: Market Size and Forecast

10.5.5 Israel: Market Size and Forecast

10.5.6 Iran: Market Size and Forecast

10.5.7 Saudi Arabia: Market Size and Forecast

10.5.8 Rest of LAMEA: Market Size and Forecast

CHAPTER 11 COMPANY PROFILES

11.1 Immucor, Inc. (TPG Capital)

11.1.1 Company overview

11.1.2 Operating business segments

11.1.3 Business performance

11.1.4 Key strategic moves & developments

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Company overview

11.2.2 Operating business segments

11.2.3 Business performance

11.2.4 Key strategic moves & developments

11.3 Thermo Fisher Scientific Inc.

11.3.1 Company overview

11.3.2 Operating business segments

11.3.3 Business performance

11.3.4 Key strategic moves & developments

11.4 F. Hoffmann-la Roche AG

11.4.1 Company overview

11.4.2 Operating business segments

11.4.3 Business performance

11.4.4 Key strategic moves & developments

11.5 Illumina, Inc.

11.5.1 Company overview

11.5.2 Operating business segments

11.5.3 Business performance

11.5.4 Key strategic moves & developments

11.6 Abbott Laboratories

11.6.1 Company overview

11.6.2 Operating business segments

11.6.3 Business performance

11.6.4 Key strategic moves & developments

11.7 Sigma-Aldrich Corporation

11.7.1 Company overview

11.7.2 Operating business segments

11.7.3 Business performance

11.8 Qiagen N.V.

11.8.1 Company overview

11.8.2 Operating business segments

11.8.3 Business performance

11.8.4 Key strategic moves & developments

11.9 Olerup SSP AB (Allenex)

11.9.1 Company overview

11.9.2 Key strategic moves & developments

11.10 DiaSorin S.P.A.

11.10.1 Company overview

11.10.2 Operating business segments

11.10.3 Business performance

11.10.4 Key strategic moves & developments

FIG. 1 TOP INVESTMENT POCKETS IN WORLD TRANSPLANT DIAGNOSTICS MARKET

FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20112016)

FIG. 3 TOP WINNING STRATEGIES: NATURE & TYPE

FIG. 4 PORTERS FIVE FORCES ANALYSIS

FIG. 5 TRANSPLANT DIAGNOSTICS MARKET TOP PLAYER POSITIONING, 2015

FIG. 6 WORLD GERIATRIC POPULATION, BY REGION, 2015

FIG. 7 TRANSPLANT PROCEDURES IN THE U.S., BY AGE, 2015

FIG. 8 WAITING LIST IN U.S. FOR ORGAN TRANSPLANTATION BY TYPE OF ORGAN

FIG. 9 U.S.: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 10 CANADA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 11 MEXICO: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 12 U.K.: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 13 GERMANY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 14 FRANCE: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 15 SPAIN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 16 ITALY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 17 TURKEY: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 18 REST OF EUROPE: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 19 AUSTRALIA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 20 SOUTH KOREA: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 21 NEW ZEALAND: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 22 CHINA: TRANSPLANT DIAGNOSTICS MARKET, (20142022) ($MILLION)

FIG. 23 JAPAN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 24 REST OF ASIA-PACIFIC: TRANSPLANT DIAGNOSTICS MARKET, (20142022) ($MILLION)

FIG. 25 BRAZIL: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 26 ISRAEL: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 27 IRAN: TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 28 SAUDI ARABIA TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 29 REST OF LAMEA TRANSPLANT DIAGNOSTICS MARKET, 20142022 ($MILLION)

FIG. 30 IMMUCOR: REVENUE, 20132015, ($MILLION)

FIG. 31 IMMUCOR: REVENUE, BY BUSINESS SEGMENT, 2015(%)

FIG. 32 IMMUCOR: REVENUE, BY GEOGRAPHY, 2015, (%)

FIG. 33 BIO-RAD: SALES, 20132015, ($MILLION)

FIG. 34 BIO-RAD: SALES, BY BUSINESS SEGMENT, 2015 (%)

FIG. 35 BIO-RAD: SALES, BY GEOGRAPHY, 2015(%)

FIG. 36 THERMO FISHER: REVENUE, 20132015 ($MILLION)

FIG. 37 THERMO FISHER: REVENUE, BY BUSINESS SEGMENT, 2015, (%)

FIG. 38 THERMO FISHER: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 39 ROCHE: REVENUE, 20132015 ($MILLION)

FIG. 40 ROCHE: REVENUE, BY BUSINESS SEGMENT, 2015(%)

FIG. 41 ROCHE: REVENUE, BY GEOGRAPHY, 2015(%)

FIG. 42 ILLUMINA: REVENUE, 20132015 ($MILLION)

FIG. 43 ILLUMINA: REVENUE, BY SEGEMNT, 2015 (%)

FIG. 44 ILLUMINA: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 45 ABBOTT: REVENUE, 20132015 ($MILLION)

FIG. 46 ABBOTT: REVENUE, BY BUSINESS SEGMENT, 2015 (%)

FIG. 47 ABBOTT: REVENUE, BY GEOGRAPHY, 20132015 ($MILLION)

FIG. 48 SIGMA-ALDRICH: REVENUE, 20132014 ($MILLION)

FIG. 49 SIGMA-ALDRICH: REVENUE, BY BUSINESS UNITS, 2014 (%)

FIG. 50 SIGMA-ALDRICH: REVENUE, BY GEOGRAPHY, 2014 (%)

FIG. 51 QIAGEN N.V.: REVENUE, 20132015 ($MILLION)

FIG. 52 QIAGEN N.V.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)

FIG. 53 QIAGEN N.V.: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 54 DIASORIN: REVENUE, 20132015 ($MILLION)

FIG. 55 DIASORIN: REVENUE, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 WORLDWIDE SCENARIO FOR CHRONIC DISEASES CAUSING DEATH

TABLE 2 TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY, 20152022 ($MILLION)

TABLE 3 TRANSPLANT DIAGNOSTICS TECHNOLOGY MARKET, BY GEOGRAPHY, 20152022 ($MILLION)

TABLE 4 NON-MOLECULAR ASSAYS MARKET, BY TECHNOLOGY, 20142022 ($MILLION)

TABLE 5 NON-MOLECULAR ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 6 SEROLOGICAL ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 7 WORLD MIXED LYMPHOCYTE CULTURE ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 8 MOLECULAR ASSAYS TECHNOLOGY MARKET, 20142022 ($MILLION)

TABLE 9 MOLECULAR ASSAYS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 10 PCR-BASED MOLECULAR ASSAY, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 11 SEQUENCING-BASED MOLECULAR ASSAY, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 12 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY COMPONENT, 20142022 ($MILLION)

TABLE 13 WORLD TRANSPLANT DIAGNOSTICS COMPONENT MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 14 WORLD TRANSPLANT CONSUMABLES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 15 WORLD TRANSPLANT DIAGNOSTICS INSTRUMENTS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 16 WORLD TRANSPLANT DIAGNOSTICS SOFTWARE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 17 WORLD TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 18 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)

TABLE 19 WORLD TRANSPLANT DIAGNOSTICS END USER MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 20 WORLD HOSPITALS AND TRANSPLANT CENTERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 21 WORLD RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 22 WORLD COMMERCIAL SERVICE PROVIDERS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 23 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATIONS, 20142022 ($MILLION)

TABLE 24 WORLD TRANSPLANT DIAGNOSTICS APPLICATIONS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 25 WORLD RESEARCH MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 26 WORLD DIAGNOSTICS MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 27 TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE, 20142022 ($MILLION)

TABLE 28 TRANSPLANT DIAGNOSTICS ORGAN TYPE MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 29 TRANSPLANT DIAGNOSTICS MARKET FOR KIDNEY, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 30 TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 31 TRANSPLANT DIAGNOSTICS MARKET FOR HEART, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 32 TRANSPLANT DIAGNOSTICS MARKET FOR LUNGS, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 33 TRANSPLANT DIAGNOSTICS MARKET FOR PANCREAS, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 34 WORLD TRANSPLANT DIAGNOSTICS MARKET FOR OTHER ORGANS, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 35 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY TYPE OF SCREENING, 20142022 ($MILLION)

TABLE 36 WORLD TRANSPLANT DIAGNOSTICS SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 37 WORLD PRE-SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 38 WORLD POST-SCREENING MARKET, BY GEOGRAPHY, 20142022 ($MILLION)

TABLE 39 WORLD TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 20142022 ($MILLION)

TABLE 40 NORTH AMERICAN TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)

TABLE 41 NORTH AMERICAN TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)

TABLE 42 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 20142022 ($MILLION)

TABLE 43 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)

TABLE 44 ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)

TABLE 45 ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)

TABLE 46 LAMEA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT, 20142022 ($MILLION)

TABLE 47 LAMEA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 20142022 ($MILLION)

TABLE 49 IMMUCOR: OPERATING SEGMENTS

TABLE 51 BIO-RAD: OPERATING SEGMENTS

TABLE 53 THERMO FISHER: OPERATING SEGMENTS

TABLE 55 ROCHE: OPERATING SEGMENTS

TABLE 57 ILLUMINA: OPERATING SEGMENTS

TABLE 59 ABBOTT: OPERATING SEGMENTS

TABLE 61 SIGMA-ALDRICH: OPERATING SEGMENTS

TABLE 63 QIAGEN N.V.: OPERATING SEGMENTS

TABLE 66 DIASORIN: OPERATING SEGMENTS

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Abbott Laboratories Inc.

Bio-Rad Laboratories Inc

F. Hoffmann-La

Roche, Ltd.

Illumina, Inc.,

Immucor, Inc.

Linkage Biosciences

Olerup Ssp Ab,

Qiagen N.V.

Thermo Fisher Scientific Inc.

Aldrich

select a license

Single User License
USD 4740 INR 305635
Corporate User License
USD 8250 INR 531960

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com